| ADTX 0.0127 -2.31% | SOXS 4.72 -5.03% | SPCX 160.95 19.22% | DFNS 0.233 -9.20% | BITO 8.65 0.12% | RUBI 0.4676 -24.62% | TZA 4.16 -2.58% | CAST 1.55 140.68% | AAL 14.98 2.25% | INTC 124.57 6.51% | SPCE 3.91 -31.76% | SHFS 0.276 16.46% | SRXH 0.148 17.65% | NOK 14.795 5.00% | NVDA 205.19 0.16% | BYAH 1.47 40.00% | SPDN 8.81 -0.45% | TQQQ 77.52 1.99% | TSLL 13.59 3.58% | PAVS 0.208 -28.28% | CPOP 0.195 -81.43% | SMCI 30.46 -4.72% | CUPR 3.97 64.73% | VSME 1.69 52.25% | YYGH 0.119 -3.25% | SQQQ 40.04 -1.93% | RKLB 102.39 -10.79% | TSLA 406.43 1.82% | NVD 5.02 -0.40% | WOK 0.0753 -17.70% | SPY 741.75 0.54% | ASTS 82.41 -15.53% | KEEL 5.59 1.27% | ONDS 9.33 -5.09% | SPYM 87.06 0.25% | AMZN 238.55 -1.23% | XLF 53.34 1.37% | SATS 114.08 -10.97% | QQQ 721.34 0.59% | SOFI 16.58 -0.54% | PLUG 2.76 -2.47% | SOXL 234.68 4.77% | GRAB 3.3 -1.49% | DRIP 4.74 -2.47% | AMC 2.34 2.63% | IREN 59.77 5.40% | HKIT 0.5025 -10.11% | RKLZ 3.01 21.37% | RZLV 2.68 5.93% | MARA 14.08 3.45%

MetLife Inc. (NYSE:MET) Quarterly Earnings Preview

MetLife Inc. (NYSE:MET) is set to release its quarterly earnings on November 5, 2025, after the market closes. Analysts have estimated an earnings per share (EPS) of $2.31, with revenue projected at $18.64 billion. MetLife is a leading global provider of insurance, annuities, and employee benefit programs, competing with companies like Prudential Financial and Aflac.

Analysts are optimistic about MetLife's performance, with the Zacks Consensus Estimate predicting an EPS of $2.33, a 20.7% increase from the previous year. This growth is driven by higher premiums, increased group benefits revenues, and strong international operations. Revenue is expected to reach $18.8 billion, reflecting a 7% year-over-year growth.

Despite these positive projections, MetLife faces challenges such as rising costs and weaker results in its Retirement and Income Solutions segment. These factors may temper profit gains. However, the earnings estimate has improved over the past month, indicating positive sentiment among analysts.

MetLife's financial metrics provide insight into its valuation and performance. The company has a price-to-earnings (P/E) ratio of approximately 12.43, showing the price investors are willing to pay for each dollar of earnings. The price-to-sales ratio is about 0.72, suggesting investors pay 72 cents for every dollar of sales.

The enterprise value to sales ratio is around 0.69, reflecting MetLife's valuation compared to its sales. The enterprise value to operating cash flow ratio is approximately 3.21, indicating how well the company can cover its enterprise value with its operating cash flow. The earnings yield is about 8.04%, providing insight into the return on investment for shareholders.

Published on: November 5, 2025